Aurora Spine Reports 1Q19 Revenue of $2.7MM, +81.2% vs. 1Q18

by Mike Evers on May 31, 2019

Aurora Spine reports 1Q19 revenue of USD $2.7MM, +81.2% vs. 1Q18.

Highest quarterly revenue in company history
Granted patent on “Expandable Interspinous Device” relating to minimally invasive implants
Completing development of posterior SI joint products and the ZIP-Flex interlaminar fixation device

...

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

	1Q19	1Q18	$ Chg	% Chg
Spine	$2.6	$1.4	$1.2	82.5%
Orthobiologics	$0.2	$0.1	$0.1	66.4%
Total	$2.7	$1.5	$1.2	81.5%

1Q19	Amount	% of Sales
Sales	$2.7
Cost of Sales	-$1.6	57.3%
Operating Expenses	-$1.4	50.2%
Net Earnings	-$0.2	-7.5%

	1Q19	1Q18	$ Chg	% Chg
Spine	$2.6	$1.4	$1.2	82.5%
Orthobiologics	$0.2	$0.1	$0.1	66.4%
Total	$2.7	$1.5	$1.2	81.5%

1Q19	Amount	% of Sales
Sales	$2.7
Cost of Sales	-$1.6	57.3%
Operating Expenses	-$1.4	50.2%
Net Earnings	-$0.2	-7.5%

Aurora Spine Reports 1Q19 Revenue of $2.7MM, +81.2% vs. 1Q18

Stryker Continues Run of Above-Market Growth

CustoMED Lands Funding to Scale AI-Powered 3D Printed Solutions

EMEA Region Driving Growth for Top Companies

Catalyst OrthoScience Secures $15.0 Million in Growth Financing

State of the Spine Market 2025

Get the ORTHOWORLD Newsletter!

Contact Us